Biofrontera (BFRI) Debt to Equity (2021 - 2024)

Biofrontera's Debt to Equity history runs 4 years deep, the most recent figure standing at $0.03 for Q2 2024.

• In Q2 2024, Debt to Equity changed N/A year-over-year to $0.03; the TTM figure through Jun 2024 stood at $0.03 (changed N/A YoY), while the FY2023 annual figure was $0.81, up 180.17% from the prior year.
• Debt to Equity was $0.03 for Q2 2024 at Biofrontera, up from -$0.43 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $6.95 in Q3 2023 to a low of -$0.43 in Q1 2024.
• Historically, Debt to Equity has averaged $1.06 across 4 years, with a median of $0.29 in 2021.
• The sharpest annual moves came in 2023 and 2024: Debt to Equity jumped 4741.7% in 2023, then sank 203.58% in 2024.
• A 4-year view of Debt to Equity shows it stood at $0.29 in 2021, then rose by 1.67% to $0.29 in 2022, then soared by 180.17% to $0.81 in 2023, then tumbled by 96.67% to $0.03 in 2024.
• The last three Debt to Equity figures came in at $0.03 (Q2 2024), -$0.43 (Q1 2024), and $0.81 (Q4 2023), per Business Quant data.